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Background: Amyloid fibrils of variable (VL) domains are the main cause of death in light chain amyloidosis.
Results: Conserved VL residue 2 is crucial for structural integrity and amyloidogenicity of VL domains.
Conclusion: Our data reveal novel insights into the architecture of variable domains in general and the prerequisite for
fibrillation.
Significance: This is important for understanding the principles of antibody structure and amyloidogenicity.
Variable (V) domains of antibodies are essential for antigen
recognition by our adaptive immune system. However, some
variants of the light chain V domains (VL) form pathogenic amy-
loid fibrils in patients. It is so far unclear which residues play a
key role in governing these processes. Here, we show that the
conserved residue 2 of VL domains is crucial for controlling its
thermodynamic stability and fibril formation. Hydrophobic side
chains at position 2 stabilize the domain, whereas charged resi-
dues destabilize and lead to amyloid fibril formation. NMR
experiments identified several segments within the core of the
VL domain to be affected by changes in residue 2. Furthermore,
molecular dynamic simulations showed that hydrophobic side
chains at position 2 remain buried in a hydrophobic pocket, and
charged side chains show a high flexibility. This results in a pre-
dicted difference in the dissociation free energy of 10 kJ
mol1, which is in excellent agreement with our experimental
values. Interestingly, this switch point is found only in VL
domains of the  family and not in VL or in VH domains, despite
a highly similar domain architecture. Our results reveal novel
insight into the architecture of variable domains and the prereq-
uisites for formation of amyloid fibrils. This might also contrib-
ute to the rational design of stable variable antibody domains.
Antibodies consist of structurally highly homologous domains
all sharing the immunoglobulin fold. This tertiary structure is
characterized by two -sheets that are connected by a con-
served disulfide bridge and form a -barrel structure. In the
variable domains, the anti-parallel -pleated sheets include
nine -strands in a 4  5 orientation (ABE(D/C)CCFG) (1),
whereas those of the constant domains are made up of seven
-strands in a 4  3 orientation (ABE(D/C)FG) (2). In the vari-
able domains, this framework structure is expanded by three
variable loops (CDR2 1–3) that mediate antigen recognition.
The principles that govern the stability of the variable domains
are of special importance, as loops of different lengths and com-
position have to be tolerated. To achieve this, the amino acid
composition of the framework is highly conserved at most posi-
tions. Single substitutions in variable domains can have delete-
rious effects, seen in some patients with monoclonal gammopa-
thy or clonal B cell dyscrasias. In these patients, antibody
variants are pathologically deposited in a fatal illness called light
chain deposition disease (3, 4) and systemic amyloid light chain
(AL) amyloidosis (5, 6). Analysis of proteins isolated from AL
patient biopsies showed that the main constituent of amyloid
deposits is the variable domain of the light chain (VL) (7, 8). The
basis of the disease is the overproduction of unpaired antibody
light chains (LCs), which are secreted into the bloodstream and
taken up by multiple organs and tissues where they aggregate,
severely compromising the functions of the affected organs and
ultimately leading to death (9, 10). AL amyloidosis remains the
most common and most fatal systemic amyloidosis in western
countries (7, 11).
Despite the high similarity between the VL and VH domains,
VH is less susceptible to amyloid fibril formation (12). Further-
more, why some VLs form amyloids and others do not still
remains largely enigmatic. In general, it is therefore not clear
which residues are of special importance for the structural
integrity of the VL domain. As the CL domain is not involved in
the deposits, it seems that structural elements exist that protect
it from misfolding (13), whereas some factors within the VL
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domain might predispose it to the disease state. Highly con-
served consensus sequences within the framework region are
potentially important elements in this respect. A striking fea-
ture of variable domains is the conserved N terminus of
-strand A (FWR1). However, the role of the N-terminal resi-
dues of the LC on domain structure, stability, and amyloido-
genic potential is still unresolved.
In this study, we performed a detailed analysis of the impor-
tance of the conserved N-terminal residues for the structural
integrity, the conformational stability, and amyloidogenicity of
variable domains. With biophysical approaches including CD,
fluorescence, NMR, and molecular dynamics (MD) simula-
tions, we demonstrate that specifically residue 2 affects the con-
formational integrity and is a key element controlling its amy-
loidogenic properties. This reveals novel insights into the
architecture of antibody variable domains.
EXPERIMENTAL PROCEDURES
Oligonucleotides (primers) were purchased from MWG Bio-
tec. Ultrapure GdmCl was obtained from Sigma. All other
chemicals were purchased from Merck. The concentrations of
GdmCl solutions were determined from refractive indices (14).
Unless stated otherwise, all measurements were carried out at
25 °C (pH 7.4) in PBS buffer.
Cloning, Mutagenesis, Expression, and Purification of the
Variable Domain Variants—The MAK33 VL wild type encod-
ing plasmid was obtained as published previously (15). 1OPG
VL, 1AQK VL, and 1VGE VH wild type sequences cloned into
a pET28b vector between the NcoI and HindIII restriction sites
were purchased from Geneart AG (Regensburg, Germany). Sin-
gle, double, and triple point mutants were generated with
QuikChange mutagenesis PCR with forward and reverse prim-
ers carrying the target mutation. Inserts of the wild type, single
point, and double point mutants in the pET28b vector were
used as PCR templates for the generation of single, double, and
triple point mutants, respectively. The PCR was followed by
digestion of template DNA with DpnI enzyme (New England
Biolabs) for 1 h at 37 °C. The PCR product was then trans-
formed through a heat shock-dependent transformation into
competent Escherichia coli Mach1 cells. Positive clones were
selected on kanamycin LB plates overnight at 37 °C. Plasmid
DNA from a single colony was isolated with the Wizard Plus SV
Miniprep kit (Promega) and sequenced using the T7 forward or
pET-RP sequencing primer by Eurofins MWG Operon to verify
the desired mutation. All MAK33 VL, 1OPG VL, 1AQK VL,
and 1VGE VH variants were expressed and purified as described
previously (15, 16). In brief, the plasmid was transformed into E.
coli BL21(DE3)-star cells (for VL and  variants) or in E. coli
JM109 cells (for VH variants) for expression at 37 °C. At an A600
of 0.6 – 0.8, expression was induced using 1 mM isopropyl -D-
thiogalactopyranoside. Cells were harvested after overnight
growth, and inclusion bodies were prepared as described pre-
viously (17, 18). The pellet was solubilized and unfolded in 25
mM Tris-HCl (pH 8), 5 mM EDTA, 8 M urea, and 2 mM -mer-
captoethanol at room temperature for at least 2 h. The soluble
fraction was then injected onto a Q-Sepharose column equili-
brated in 25 mM Tris-HCl (pH 8), 5 mM EDTA, and 5 M urea.
The proteins were eluted in the flow-through and diluted two
times before being refolded by dialysis into 250 mM Tris-HCl
(pH 8.0), 100 mM L-Arg (for VL and  variants) or 400 mM
L-Arg (for VH variants), 5 mM EDTA, 1 mM oxidized glutathi-
one, and 0.5 mM reduced glutathione at 4 °C overnight. To
remove misfolded aggregates and remaining impurities, the
protein was cleaned using a Superdex 75 gel filtration col-
umn (GE Healthcare) equilibrated in PBS buffer. The recov-
ery and purity of intact protein were verified by SDS-PAGE
and matrix-assisted laser desorption/ionization time-of-
flight mass spectrometry.
CD Measurements—CD measurements were performed using a
Jasco J-720 spectropolarimeter (Jasco, Grossumstadt, Ger-
many) equipped with a Peltier element. Far-UV CD spectra
were measured using 10 M protein in a 1-mm path length
cuvette between 260 and 200 nm. Near-UV CD was measured
between 320 and 250 nm using 50 M protein in a 1-mm
cuvette. All spectra were accumulated 16 times, and buffer was
corrected. Thermal transitions were recorded using 10 M pro-
tein at 212 nm for VL and 205 nm for VL and VH variants with
a heating and cooling rate of 20 °C/h.
Tryptophan Fluorescence Measurements—Unless otherwise
stated, all fluorescence measurements were carried out using a
FluoroMax-4 spectrofluorimeter (Horiba Jobin Yvon, Ben-
sheim, Germany). Tryptophan fluorescence measurements
were performed with excitation and emission slit widths of 2
and 3 nm, respectively. The protein concentration in a 1-cm
quartz cuvette was 1 M. The sample was excited at 280 nm, and
spectra were recorded between 300 and 450 nm. Equilibrium
unfolding and refolding transitions were carried out by dena-
turing 1 M protein overnight at different concentrations of
GdmCl (between 0 and 3 M GdmCl). Fluorescence intensity at
358 nm was measured for 50 s, and the average was taken. Anal-
ysis of data was carried out using the linear extrapolation
method described previously (14, 19).
1-Anilino-8-naphthalene Sulfonate (ANS) Binding Assay—
ANS binding was measured by fluorescence emission recorded
from 400 to 650 nm, with excitation at 380 nm with excitation
and emission slit widths of 2 and 3 nm, respectively. Experi-
ments were performed at a protein concentration of 10 M and
an ANS concentration of 100 M in 1-cm quartz cuvette. All
spectra were accumulated three times and averaged.
Fibril Formation with Ultrasonication—For the standard
reaction, the VL variants were diluted at a concentration of 30
M in PBS solution and 5 M thioflavin T (ThT). Then 0.2 ml of
the VL variant solution was applied to each of the 96 wells of a
microplate (Greiner Bio-One on a 96-well microplate 675-074
made of polystyrene with a size of 128  85 mm). The micro-
plate was set on the HANABI (HANdai Amyloid Burst
Inducer), which combines the use of a water bath-type ultra-
sonicator (ELESTEIN, Elekon, Chiba, Japan) and a microplate
reader (SH-9000, Corona Electric Co., Ibaraki, Japan). The
water bath with 400  250 mm  230 nm (height) contains
about 12 liters of water, and three ultrasonic transducers are
set, two on the sides and one at the bottom. Pulses were applied
to the microplate from three directions, focusing on the center
position, for cycles of 1 min followed by a quiescent period of 9
min. The measurement temperature was maintained at 37 °C.
The formation of fibrils was monitored by ThT fluorescence
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with excitation and emission wavelengths of 450 and 490 nm,
respectively. Microplates were incubated at 37 °C and shaken
before the measurements. Transmission electron micros-
copy (TEM) images were taken using a HITACHI H-7650
transmission microscope, (Hitachi, Tokyo, Japan), with an
acceleration voltage of 80 kV. Aliquots (5 l) of the samples
were placed on a 400-mesh copper grid covered by a carbon-
coated colloidal film for 60 s. Two percent (w/v) uranyl ace-
tate solution (5 l) was then placed on the grid to stain the
samples for 60 s. Excess sample solutions on the grid were
removed with a filter paper. The magnification on the rep-
resentative pictures was 30,000-fold.
Fibril Formation without Ultrasonication—Samples of VL at
a concentration of 30 M in PBS buffer (pH 7.4), containing
0.05% sodium azide (or acetate buffer (pH 2)) were incubated
with shaking (gentle agitation) in a roller shaker at 37 °C for at
least 1 week. At various intervals, a 20-l aliquot was with-
drawn for ThT binding and TEM. For the ThT binding, 10 l of
protein aliquot was added to 480 l of a PBS buffer (pH 7.4)
followed by the addition of 10 l of 500 M ThT prepared in
PBS buffer (pH 7.4) (ThT final concentration 10 M). This was
left to incubate for 90 s before acquiring the emitted signal in a
1-cm quartz cuvette from 430 to 570 nm with excitation at 440
nm. The spectra were recorded using an FP-6500 spectrofluo-
rimeter (Jasco) equipped with a Jasco ADP-303T Peltier as tem-
perature controller. The excitation and emission slit widths
were both 3 nm. A scan speed of 100 nm/min, an integration
time of 1 s, and a 0.5-nm recording interval were used. Three
scans were averaged for each sample. Rayleigh (elastic) light
scattering at an angle of 90° was also measured at the excitation
wavelength peak of 440 nm (20, 21). Therefore, for the same
sample, information on its light scattering ability (presence of
macromolecular assemblies or aggregation) and ThT binding
(fibril formation) was assessed. For comparison, the Rayleigh
scattering intensity at 440 nm and the ThT fluorescence inten-
sity at 480 nm were used.
For TEM measurements, a 10-l protein aliquot was fixed on
a 200-mesh activated copper grid and incubated for 60 s. After
a washing step with 10 l of H2O, the samples were stained with
10 l of a 1.5% uranyl acetate solution. Samples were recorded
with an acceleration voltage of 100 kV at a magnification of
33,000 on a transmission electron microscope JEM100CX
(Jeol).
Thermally Induced Aggregation—Native MAK33 or 1OPG
VL at a concentration of 10 M in PBS buffer (pH 7.4) with 10
M ThT was subjected to increasing temperatures from 20 to
80 °C in steps of 5 °C in a 1-cm path cuvette. After thermal
equilibration for 3 min, emission spectra were recorded for
Rayleigh scattering and ThT fluorescence (21) as stated under
“Fibril Formation without Ultrasonication.”
NMR Spectroscopy—All NMR spectra were recorded using
uniformly 15N,13C-labeled proteins in 20 mM phosphate, 50 mM
NaCl (pH 6.5) at 298 K. Backbone resonance assignments of
MAK33 VL-WT and MAK33 VL-I2E were transferred
from previous assignments of MAK33 VL-S20N (data not
shown). The assignment was accomplished based on three-
dimensional HNCA, HNCACB, CBCACONH, HNCO, and
HNCACO experiments (22). Experiments were carried out
at 1 mM protein concentration. Those residues, for which the
assignment could not be transferred from MAK33 VL-S20N,
were assigned based on an HNCA experiment using a 100 M
MAK33 VL-I2E sample. All spectra were recorded on a Bruker
AVANCE 900MHz spectrometer (Bruker Biospin) equipped
with a triple-resonance cryoprobe. Spectra were processed
using TOPSPIN 3.2 (Bruker BioSpin) and analyzed with
CcpNmr 2.2.2 (23). For determination of residues affected by
the I2E substitution, 15N HSQC spectra of MAK33 VL-WT
and MAK33 VL-I2E, both at 50 M, were acquired on a Bruker
Avance 600MHz spectrometer equipped with a cryoprobe. For
all residues, chemical shift perturbations were determined
using Equation 1,
res  1H	2  125  15N	2
with res being the weighted chemical shift difference, 1H as
the chemical shift of the amide proton in ppm, and 15N as the
chemical shift of the amide nitrogen in ppm.
For comparison of signal intensities, all signals, which dis-
played significant overlap in one of the proteins, were ignored.
Intensities were normalized for both proteins to the same aver-
age intensity.
MD and Umbrella Sampling (US) Simulations—Start struc-
tures of MAK33 VL domains and VL and VH domains were
obtained by extracting the corresponding coordinates from the
crystal structures 1FH5 (MAK33 VL), 1OPG, 1AQK, and
1VGE. Residue 2 of MAK33 VL, 1AQK VL, 1VGE VL, and
1VGE VH was substituted in silico with Glu although residue 2
of 1OPG, and VL was replaced with Ile. In silico substitutions
were performed using the SPDBV package (24), while selecting
the best fitting side chain rotamer. All MD simulations and the
analysis of root mean square deviations (r.m.s.d.) and fluctua-
tions were performed using the Amber12 package (25). Pro-
teins were solvated in octahedral boxes, including explicit ions
and explicit (TIP3P) water molecules (26). The simulation sys-
tems were first energy-minimized (5000 steps) followed by
heating up to 300 K in steps of 100 K with position restraints on
all heavy atoms of the proteins. Subsequently, positional
restraints were gradually removed from an initial 25 kcal mol
1
Å
2 to 0.5 kcal mol
1 Å
2 within 0.5 ns followed by a 1-ns
unrestrained equilibration at 300 K. All production simulations
were performed at a temperature of 300 K and a pressure of 1
bar. US simulations were performed using the distance between
the C	 atom of residue 2 and the C	 of residue 32 at the floor of
the binding region for residue 2 in the VL domains as a reac-
tion coordinate. A quadratic penalty potential (k (dC	-C	 
 dref)2,
force constant k  2.0 kcal mol
1 Å
2) for the C	-C	 distance
was used with reference distances varying from 11.5 to 16 Å in
0.5-Å steps and from 16 to 20 Å in 1-Å steps. At 12–13 Å,
residue 2 stays bound to the protein in the cavity as observed in
the experimental x-ray structure, whereas it adopts a fully
exposed state at distances of 16 Å. The associated potential of
mean force was calculated using the weighted histogram anal-
ysis method (27).
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Biophysical Characteristics, Stability, and Amyloidogenic
Propensity of Two Highly Homologous VL Domains—MAK33
is a well studied IgG antibody with respect to folding and asso-
ciation. In this context, the folding pathway of the VL domain
has been analyzed in detail (15); its amino acid composition is
typical for a murine /IgG1 light chain variable domain (PDB
code 1FH5 (28)). Interestingly, another antibody VL domain
exists (PDB code 1OPG (29)), which has identical CDRs but five
differences in the framework region (Fig. 1a). We were wonder-
ing whether these differences affect the structural properties of
the domain. Both isolated domains were expressed, purified,
and characterized. The far-UV circular dichroism (CD) spectra
of the VL domains were similar with a minimum at 218 nm
(Fig. 1b) characteristic of the -sheet conformation. However,
the shapes of both native spectra suggest a large contribution of
random coils, which might be due to long flexible CDR loops.
Their near-UV CD spectra (Fig. 1c) with a minimum at 275 nm
confirmed that the tertiary structure of both proteins is cor-
rectly formed (30, 31). The presence of a buried tryptophan in
close proximity to the disulfide in antibody domains makes it a
sensitive probe for studying conformational changes by fluores-
cence. Intrinsic tryptophan fluorescence spectra of both VL
domains showed MAK33 VL to have a large (2.5-fold)
increase in fluorescence emission intensity (maximum at 358
nm) in the presence of 3 M GdmCl (Fig. 1d), as opposed to a
small increase observed in 1OPG VL (Fig. 1e). This suggests
already a partial exposure of tryptophan in the native 1OPG
VL. To verify whether the VL domains exposed hydrophobic
patches on their surfaces, ANS binding assay was performed. As
depicted in Fig. 1f, 1OPG VL binds ANS with an increase and
a blue-shifted fluorescence emission maximum (shift from 525
FWR3 CDR3 FWR4
FWR1 CDR1 FWR2 CDR2
(a)
1FH5_MAK33 DIVLTQSPAT LSVTPGESVS LSCRASQSIS N-----NLHW YQQKSHESPR LLIKYASQSI
1OPG_VLk DELLTQSPAT LSVTPGDSVS LSCRASQSIS N-----NLHW YQQKSHESPR LLIKYASQSI
1VGE_VLk     ELVMTQSPSS LSASVGDRVN IACRASQGIS S-----ALAW YQQKPGKAPR LLIYDASNLE 
1QLR_VLk     EIVLTQSPAT LSLSPGERAT LSCGASQSVS SN----YLAW YQQKPGQAPR LLIYDASSRA 
1TET_VLk     DVLMTQTPLS LPVSLGDQAS ISCKSSQSIV HSSGNTYFEW YLQKPGQSPK LLIYKVSNRF 
: ::**:* : *. : *: .. ::* :**.:         : * * **. ::*: ***  .*.   
1FH5_MAK33 SGIPSRFSGS GSGTDFTLSI NSVETEDFGM YYCQQSNSWP LTFGAGTKLE LK
1OPG_VLk SGIPSRFSGS GSGTDFTLSI NSVETEDFGM YFCQQSNSWP LTFGGGSKLE IK
1VGE_VLk     SGVPSRFSGS GSGTDFTLTI SSLQPEDFAI YYCQQFNSYP LTFGGGTKVE IK
1QLR_VLk     TGIPDRFSGS GSGTDFTLTI SRLEPEDFAV YYCQQYGSSP LTFGGGTKVE IK






FIGURE 1. Sequence analysis of VL domains, spectroscopic characterization of MAK33 VL and 1OPG VL. a, multiple sequence alignment of VL
sequences. Five representative sequences are shown. MAK33 VL differs from 1VGE VL at 40 positions and from 1OPG VL at five positions as marked by red
rectangles. Identical CDRs between MAK33 VL and 1OPG VL domains are highlighted in different colors. b, far-UV CD spectra of native (continuous line) and
temperature-denatured (dotted line; 60 °C) MAK33 VL and 1OPG VL in PBS buffer. c, near-UV CD spectra of native MAK33 VL (green line) and 1OPG VL (blue
line). Intrinsic tryptophan fluorescence spectra of native (continuous line) and 3 M GdmCl-denatured (dotted lines) MAK33 VL (d) and 1OPG VL (e) in PBS buffer.
f, ANS fluorescence spectra of native MAK33 VL (green line) and 1OPG VL (blue line). The gray line is PBS/ANS without protein. g, thermally induced aggregation
of MAK33 VL and 1OPG VL domains monitored by Rayleigh (elastic) light scattering at 440 nm.
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to 515 nm), suggesting the presence of exposed hydrophobic
patches. MAK33 VL shows no ANS binding (Fig. 1f).
The propensity of both MAK33 and 1OPG VL domains to
aggregate with increasing temperatures was monitored by
recording Rayleigh (elastic) scattering of ThT fluorescence
excitation (440 nm) light (Fig. 1f) (20, 21). Surprisingly, 1OPG
VL already starts aggregating at 35 °C, although MAK33 VL
only starts transforming into aggregates at 50 °C (a difference
of 15 °C). Maximum aggregation for both proteins occurred
at 65 °C. No ThT binding was observed for any of the proteins
at the experimental temperature range of 20 – 80 °C (data not
shown), which implies that the aggregates formed by thermal
induction did not contain amyloid fibrils. When we determined
their stabilities against temperature monitored by far UV CD,
we found, interestingly, that the 1OPG VL is 16 °C less stable
than MAK33 VL as judged from their transition midpoints
(Fig. 2b), which correlates very well with thermal-induced
aggregation monitored by light scattering at 440 nm. Thermally
induced unfolding transitions were not reversible for any of the
proteins. For equilibrium unfolding and refolding in the pres-
ence of GdmCl monitored by Trp fluorescence, the MAK33
VL with a cooperative sigmoidal transition had identical mid-
points in both the unfolding and refolding directions (Fig. 2c).
This sigmoidal transition was not observed for 1OPG VL, for
which a native baseline could not be obtained (Fig. 2c). The
GdmCl-induced unfolding transitions were cooperative and
reversible. Assuming two-state transitions, the data were fitted
using linear extrapolation (14, 19) that yielded an intrinsic sta-
bility of 
17.8 kJ mol
1 for MAK33 VL and 
3.0 kJ mol
1 for
1OPG VL and m values of 18.0  2.4 and 12.9  5.3, respec-
FIGURE 2. Stability and amyloidogenic propensity of MAK33 VL and 1OPG VL domains. a, thermal unfolding transitions of MAK33 VL (green symbols)
and 1OPG VL (blue symbols). The solid lines indicate the theoretical curves derived by fitting the data to a Boltzmann function for MAK33 VL (green) and 1OPG
VL (blue) to obtain transition midpoints (Tmelt). b, GdmCl-induced unfolding transitions of MAK33 VL (green) and 1OPG VL (blue). The reversibility of the
GdmCl-induced unfolding process is shown by the overlay of unfolding symbols (open circles) and refolding (closed circles) experiments. The solid lines show the
fit to a two-state mechanism for both MAK33 VL (green line) and 1OPG VL (blue line) to obtain thermodynamic stability values (GU) and the cooperativity
parameters (m values). c, transmission electron microscopy micrographs of MAK33 VL and 1OPG VL from amyloid induction experiments at neutral pH, 37 °C,
and 1 week incubation with gentle agitation. Scale bars, 200 nm.
Role of Residue 2 for Integrity of Antibody Variable Domains





















tively, which reflects the different cooperativities observed.
Although the stability of MAK33 VL falls within the range of
those reported for amyloidogenic VL domains (15–20 kJ
mol
 1) (32, 33), it is known to be nonamyloidogenic in vitro at
physiological pH (15). Accordingly, after 1 week of incubation
in PBS buffer at pH 7.4 and 37 °C with gentle agitation, MAK33
VL did not form any amyloid fibrils (Fig. 2c). However, under
these conditions, 1OPG VL readily turned into well defined
fibrillar structures (Fig. 2c). When the proteins were incubated
in an acidic buffer (pH 2) under similar conditions, fibrils were
detected for both MAK33 VL and 1OPG VL samples (data
not shown), confirming our previous results on MAK33 VL
(15). This supports the notion that under appropriate destabi-
lizing conditions, even proteins not known to form amyloid
fibrils under normal physiological conditions can indeed fibril-
lize (34 –36).
To assess how conserved the frameworks of both VL
domains are in comparison with other VL sequences, a com-
prehensive sequence analysis was performed using the abYsis
database, which integrates sequences from the Kabat (37) and
IMGT (38) databases. Fig. 1a depicts five representative VL
sequences from this alignment. Considering amino acid side
chain chemistry, all framework residues are very similar, except
for residue 2. In 1OPG VL, this residue is a Glu, although in
most other VL frameworks an aliphatic residue is found at the
same position (Fig. 1a). A residue frequency distribution anal-
ysis using the abYsis database with all available (20,000 non-
identical) LC sequences revealed that Ile occurs with the high-
est frequency (46%) at position 2 (Fig. 3). Other aliphatic
residues like Val, Leu, and Ala represent 7–9% at this position in
VL domains and charged residues (Glu, Asp, Lys, and Arg) only
1% (Fig. 3a). In addition, looking at the residue frequency
distribution at position 102 of these VL domains, we observed a
highly conserved Thr with a frequency of 98%, although all
other residues had a 1% frequency of occurrence (Fig. 3d). In
the more conformationally stable MAK33 VL, position 102 is
occupied by Thr, whereas in the less stable 1OPG VL, the less
frequent Ser is found. With positions 2 and 102 showing huge
frequency distribution discrepancies between the two VL
domains, we wondered whether these positions were responsi-
ble for the different behaviors of the two proteins. In conse-
quence, we exchanged these residues between the two VL
domains and monitored their effects on stability and amyloid
fibril formation.
Residue 2 Is Crucial for the Stability of VL Domains—To
identify residue(s) that predispose 1OPG VL for lower stability
and fibril formation, single point variants were generated by
replacing residues in 1OPG VL with corresponding residues of
MAK33 VL at any of the five different positions (OP-E2I,
OP-L3V, OP-G100A, OP-S102T, and OP-I106L). All five sub-
stitutions were correctly folded as revealed by UV CD spectra.
The thermal unfolding of these variants showed a striking
increase in thermal stability for OP-E2I with a Tmelt value of
43.1 °C, compared with 31.6 °C for 1OPG VL-WT. Also,
OP-E2I was significantly more stable toward GdmCl than
1OPG VL-WT (Fig. 4, a and c; Table 1). OP-S102T was only
slightly more stable, and the other single point substitution





FIGURE 3. Residue frequency distribution analysis at position 2 of variable domains and of the different positions between MAK33 VL and 1OPG VL
domains. Relative distribution of amino acid at various positions of light (a– e) and heavy chains (f). Green arrowheads indicate residue in MAK33 VL, and the
corresponding positions in 1OPG VL are shown by blue arrowheads. With the exception of positions 100 and 106, the residues found in MAK33 VL at positions
2, 3, and 102 are more frequent than those at corresponding positions in 1OPG VL. The database could not separate  LCs from the  LCs during the
distribution analysis. But an observation of most of the sequences show that Ser-2 is almost entirely contributed by the  LCs (orange arrowhead in a). f, red
arrowheads indicate the most frequent residue at position 2 of heavy chains. Sequences from all organisms were considered for the analysis. Analysis was based
on the Kabat numbering scheme accessed through the antibody (abYsis database) (Dr. Andrew C. R. Martin’s Group, University College London).
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FIGURE 4. Stability of the different VL variants. Thermal unfolding transitions of 1OPG VL variants (a), MAK33 VL variants (b), and 1VGE VL variants (d). The
solid lines indicate the theoretical curves derived by fitting the data to a Boltzmann function to obtain transition midpoints (Tmelt). c, increase or decrease in
stability caused by the different substitutions in 1OPG VL and MAK33 VL, obtained by subtracting the Tmelt and GU values of the wild type VL from those of
their corresponding mutants. e, GdmCl-induced unfolding transitions of 1VGE VL variants. The reversibility of the unfolding process is shown by the overlay
of unfolding symbols (open circles) and refolding (closed circles) experiments. The solid lines show the fit to a two-state mechanism for VL variants to obtain
thermodynamic stability values (GU) and the cooperativity parameters (m values).
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1), implying that the exchange of these residues is not impor-
tant for the conformational stability of the domain. With the
high increase in stability seen in OP-E2I and the small increase
observed in OP-S102T, we next tested whether a combination
of both substitutions (OP-E2I/S102T) and a triple substitu-
tion OP-E2I/G100A/S102T (OP-IAT) would further lead to
increased stability. The double and triple substitution variants
both unfolded with a Tmelt of about 45 °C quite similar to that
obtained for OP-E2I (Table 1), confirming only a small influ-
ence of the G100A and S102T substitutions on the thermal
stability of the protein. However, in terms of stability to GdmCl,
both variants were more stable than the respective single sub-
stitution variants (Fig. 4c; Table 1). These stability values
observed for the double and triple substitution variants of
1OPG VL are similar to that of MAK33 VL wild type (Table
1). This demonstrates an additive effect of exchanges at differ-
ent positions.
Because Glu-2 and Ser-102 to a minor extent were deter-
mined to be the destabilizing residues in 1OPG VL, we were
also interested in how they affect MAK33 VL. Interestingly,
MK-I2E was destabilized, whereas MK-T102S had stability val-
ues similar to that of MAK33 VL-WT (Fig. 4, b and c; Table 1).
Specifically, MK-I2E was 10 °C less stable with a free energy of
12 kJ mol
1 less than that of MAK33 VL-WT. The com-
bined substitution variant (MK-I2E/T102S) was less stable than
both single substitution variants with a Tmelt of 33.6 °C and a
chemical stability of 
8.0 kJ mol
 (Fig. 4c; Table 1). This again
emphasizes the additive effect of both positions. To demon-
strate that our findings on the pivotal role of residue 2 are gen-
eral to the VL family, we investigated a human /IgG1 anti-
body VL domain (1VGE VL) (39), which differs greatly in
amino acid sequence from 1OPG and MAK33 VL. The N-ter-
minal motif is ELV as opposed to DIV in MAK33 and DEL in
1OPG VL (Fig. 1a). To assess the role of residue 2 in this
human VL, Leu was replaced with Glu (1VGE VL-L2E). Nota-
bly, analysis of their thermal and thermodynamic stabilities also
revealed a decrease in thermal stability of 10 °C and a 2-fold
decrease in thermodynamic stability for 1VGE VL-L2E com-
pared with the wild type (Fig. 4, d and e; Table 1). This correlates
very well with results obtained for MAK33 and 1OPG VL,
implying that the effects mediated by residue 2 are conserved
within the VL family.
Influence of Sequence Variation on Amyloid Fibril Forma-
tion—To examine whether the increase in the stability of 1OPG
VL variants also correlates with the resistance to amyloid for-
mation, we set up ultrasonication amyloid induction assays at
neutral pH at 37 °C (40 – 45). ThT fluorescence was used to
monitor the fibrillation process (46, 47). All variants that had a
thermodynamic stability of 10.0 kJ mol
1 (Table 1) bound
ThT as indicated by an increase in fluorescence after a lag time
of several hours, whereas the more stable variants (OP-E2I/
S102T, OP-IAT, MAK33 VL-WT, and MK-T102S) showed no
ThT fluorescence (Fig. 5, a and b). The large fluctuations in
ThT fluorescence amplitude are likely due to differences in
higher order structure of amyloid fibrils as ThT fluorescence
can change depending on the morphology of amyloid fibrils
(41– 43, 48). These variations in ThT fluorescence amplitudes
might also depend on the mutants, and it is worth noting that
ThT fluorescence is not always proportional to the amount of
amyloid fibrils (48).
To confirm the presence of fibrils, transmission electron
microscopy was performed. As expected, amyloid fibrils were
detected in all variants for which ThT fluorescence was
observed (Fig. 5c). Similar results were obtained with gentle
agitation without ultrasonication after 4 or 10 days of incuba-
tion of the VL variants (data not shown). However, although
the stable variants were protected from amyloid fibril forma-
tion, they did transform into amorphous aggregates upon pro-
longed incubation at 37 °C, revealed by the increase in Rayleigh
scattering intensity (data not shown) Thus, the changes in VL
domain stability induced by modulating residue 2 inversely cor-
related with its ability to form amyloid fibrils.
Residue 2 Is a Decisive Factor for VL Domain Architecture—
Alignment of VL sequences revealed a highly conserved N
terminus for this family, with residue 1 always being an acidic
residue (Asp or Glu) and residue 2 mostly an aliphatic residue
(Ile, Leu, or Val) (Fig. 1a). We wondered whether the conserved
residue 1 also affects the stability of VL. Thus, N-terminal
truncation variants of MAK33 VL were generated in which
either the first residue (Asp-1) was deleted (MK-VLD1) or one
in which both the first (Asp-1) and the second (Ile-2) residues
were truncated (MK-VLD1/I2). Deletion of these N-terminal
residues did not influence the structure of the domain as deter-
mined by CD spectroscopy. Surprisingly, the deletion of Asp-1
(MK-VLD1) did not lead to changes in the thermodynamic
stability when compared with the wild type domain. In contrast,
the deletion of both Asp-1 and Ile-2 (MK-VLD1/I2) resulted
in a decrease in Tmelt and thermodynamic stability of 7 °C and
10 kJ mol
1, respectively (Fig. 6, a and b; Table 1), which is
similar to the stability obtained by substituting Ile-2 alone with
Glu (MK-I2E). These results show that residue 2 and not resi-
due 1 is important for the stability of VL domains.
With Glu at position 2 identified to be destabilizing and Ile or
Leu at the same position are stabilizing, we were interested to
determine how residues with other side chains might affect the
stability of these VL domains. Considering the residue fre-
quency distribution at position 2 of VL (Fig. 3a), residue 2 of
TABLE 1
Thermal and chemical stabilities of 1OPG VL and MAK33 VL and
1VGE VL variants
Stabilities against the thermal and chemical (GdmCl) denaturation of different vari-
ants are shown. Midpoints of thermal transitions are shown as Tmelt. Because the
GdmCl-induced unfolding transitions were reversible, the data were fitted to a
two-state equilibrium unfolding model to obtain the thermodynamic stability of
unfolding (GU), as well as the cooperativity parameter (m value), for a qualitative
comparison of the data.





1OPG VL-WT 31.6  0.2 
3.0  2.6 12.9  5.3
OP-E2I 43.1  0.1 
5.8  1.7 14.2  1.7
OP-S102T 34.0  0.2 
6.0  1.6 16.6  3.3
OP-E2I/S102T 45.8  0.2 
13.8  3.9 18.1  4.4
OP-E2I/G100A/S102T 44.8  0.4 
14.8  4.0 16.4  4.0
MAK33 VL-WT 47.7  0.2 
17.8  2.6 18.0  2.4
MK-I2E 38.2  0.1 
5.8  1.6 15.0  3.0
MK-T102S 46.0  0.2 
13.8  3.1 18.2  3.2
MK -I2E/T102S 33.6  0.2 
8.0  3.0 19.8  2.3
MK-D1 48.2  0.2 
14.2  3.7 13.5  3.3
MK-D1/I2 41.7  0.1 
9.7  1.7 15.6  2.5
1VGE VL-WT 46.0  0.1 
.3  0.4 10.7  0.5
1VGE VL-L2E 38.6  0.2 
4.8  0.6 10.7  1.0
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1OPG VL-WT and MAK33 VL-WT were replaced with Ala,
Leu, Asp, Lys, or Gln. Interestingly, the thermal unfolding tran-
sitions of these variants revealed striking differences. All vari-
ants with an uncharged residue at position 2 had a high thermal
stability (Table 2). Although the respective 1OPG VL variants
showed an increase in Tmelt of 4 –12 °C compared with their
FIGURE 5. Amyloidogenicity of VL variants. 30 M of each VL variant in a PBS buffer at pH 7.4 in the presence of ThT was subjected to ultrasonic pulses at
37 °C (n  3). ThT fluorescence was monitored over time for 1OPG VL variants (a) and MAK33 VL variants (b), and TEM micrographs (c) were acquired at the
end of the assay to detect the presence of fibrils. Variants with higher thermodynamic stabilities (10 kJ mol
1), OP-E2I/S102T and OP-IAT in a and MK-VL-WT
and MK-T102S in b, did not bind ThT, and as a result the curves of both proteins are superimposed.
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wild type, MAK33 VL variants with the same uncharged resi-
dues at position 2 had Tmelt values similar to the more stable
MAK33 VL-WT (Fig. 6e; Table 2). However, all variants with a
charged residue (whether positive or negative) at position 2
were strongly destabilized. OP-E2D and OP-E2K were as unsta-
ble as 1OPG VL-WT, whereas the same substitutions in
MAK33 VL resulted in an 10 °C decrease in Tmelt (Fig. 6e;
Table 2).
Residue 2 Does Not Affect the Stability of VL and VH
Domains—Irrespective of the family, variable domains (VL,






(c) 1OPG VLκ variants
MAK33 VLκ variants
FIGURE 6. Stability of the different MAK33 VLN-terminal variants and the different position mutants. a, thermal unfolding transitions of MAK33 VLN-terminal
variants. The solid lines indicate the theoretical curves derived by fitting the data to a Boltzmann function to obtain transition midpoints (Tmelt). b, GdmCl-induced
unfolding transitions of MAK33 VL N-terminal variants. The reversibility of the unfolding process is shown by the overlay of unfolding symbols (open circles) and
refolding (closed circles) experiments. The solid lines show the fit to a two-state mechanism for VL variants to obtain thermodynamic stability values (GU) and the
cooperativity parameters (m values), for a qualitative comparison of the data. c, increase or decrease in stability caused by different amino acid substitutions at position
2 of 1OPG VL and MAK33 VL, obtained by subtracting the Tmelt value of the wild type VL from those of their corresponding mutants.
TABLE 2
Thermal stabilities of various substitutions of residue 2 of 1OPG VL
and MAK33 VL variants
Stabilities against thermal denaturation of the different 1OPG VL and MAK33 VL
residue two variants are shown. Midpoints of the thermal transitions are shown as Tmelt.
1OPG VL variant Tmelt MAK 33 VL variant Tmelt
°C °C
1OPG VL-wt 31.6  0.2 MAK33 VL-WT 52.0  0.5
OP-E2I 43.1  0.1 MK-I2E 44.0  0.4
OP-E2A 38.4  0.2 MK-I2A 49.2  0.4
OP-E2L 38.5  0.2 MK-I2L 50.0  0.5
OP-E2Q 35.1  0.2 MK-I2Q 46.3  0.4
OP-E2D 30.3  0.6 MK-I2D 42.5  0.4
OP-E2K 31.3  0.4 MK-I2K 43.4  0.5
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a conserved framework. We were interested to determine
whether residue 2 also plays a similar role in the VL and in the
VH domains. A multiple sequence alignment (Fig. 7, a and b)
and a residue frequency distribution analysis at position 2 of
VL and VH showed this position in VL to be mostly occupied
by Ser or Ala (Fig. 3a), although at the same position in VH
domains, Val occurs with a frequency of 83% (Fig. 3f). To ascer-
tain the effects of residue 2 in these variable domains, a human
/IgG VL (1AQK (49)) and a human IgG1 VH (1VGE (39))
were examined. In the 1AQK VL domain, residue 2 (Asn-2)
was replaced with either a Glu (1AQK VL-N2E) or Ser (1AQK
VL-N2S). Unexpectedly, stability studies did not reveal any
differences between the wild type and the 1AQK VL-N2E
mutant (Fig. 7, c and d; Table 3). This suggests that the stabiliz-
(a)
1AQK_VLλ ENVLTQPPSV SGAPGQRVTI SCTGSNSNIG AGFTVHWYQH LPGTAPKLLI FANTNRPSGV
1NGP_VLλ QAVVTQESAL TTSPGETVTL TCRSSTGAVT TSNYANWVQE KPDHLFTGLI GGTNNRAPGV 
2FB4_VLλ QSVLTQPPSA SGTPGQRVTI SCSGTSSNIG S-STVNWYQQ LPGMAPKLLI YRDAMRPSGV 
4BJL_VLλ ESVLTQPPSA SGTPGQRVTI SCSGSSSNIG E-NSVTWYQH LSGTAPKLLI YEDNSRASGV 
1MCS_VLλ PSALTQPPSA SGSLGQSVTI SCTGTSSDVG GYNYVSWYQQ HAGKAPKVII YEVNKRPSGV 
.:** .:  : : *: **: :* .:.. :      . * *.  ..   . :*      *..** 
(b)
1VGE_VH    QVKLLEQSGA EVKKPGASVK VSCKASGYSF TSYGLHWVRQ APGQRLEWMG WISAGTGNTK 
1OPG_VH     EVQLVQSGG GLVNPGRSLK LSCAASGFTF SSYGMSWVRQ TPEKRLEWVA AISGGGTYIH 
1AQK_VH     EVQLVESGG GVVQPGRSLR LSCAASGFTF NNYAIHWVRQ APGKGLEWVA FISYDGSKNY 
1TET_VH     QIQLVQSGP ELKTPGETVR ISCKASGYTF TTYGMSWVKQ TPGKGFKWMG WINTYSGVPT 
7FAB_VH     AVQLEQSGP GLVRPSQTLS LTCTVSGTSF DDYYWTWVRQ PPGRGLEWIG YVFYTG-TTL 










FIGURE 7. Multiple sequence alignment of VL (a) and VH (b) domains is irrespective of organism. Five representative sequences are shown. Only the first 60
residues are presented. All sequences have a less diverse framework within each family. The N terminus of VL is mostly a QAV, ESV, or PSV motif with Ser the
most frequent at position 2. In VH, the N terminus is mostly an EVQ, AVQ, or QVK motif with Val the most frequent residue at position 2. Stability of 1AQK VL and
1VGE VH variants; thermal unfolding transitions of the different 1AQK VL (c) and 1VGE VH variants (e). The solid lines indicate the theoretical curves derived by
fitting the data to a Boltzmann function to obtain transition midpoints (Tmelt). d, GdmCl-induced unfolding transitions of 1AQK VL variants monitored by
tryptophan fluorescence. The reversibility of the unfolding process is shown by the overlay of unfolding symbols (open circles) and refolding (closed circles)
experiments. The solid lines show the fit to a two-state mechanism for all 1AQK VL variants to obtain thermodynamic stability values (GU) and the cooper-
ativity parameters (m values). GdmCl-induced unfolding transitions of 1VGE VH variants could not be performed due to less protein amounts.
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ing effects of residue 2 seen in the VL family cannot be ascribed
to the VL family. Moreover, the mutant that contained Ser at
position 2 (1AQK VL-N2S) was slightly more stable than the
wild type and 1AQK VL-N2E mutant. When Val-2 of 1VGE
VH was substituted with a Glu (1VGE VH-V2E) or Ala (1VGE
VH-V2A), again no pronounced thermal stability differences
were observed (Fig. 7e; Table 3). Both 1VGE VH-V2E and 1VGE
VH-V2A mutants were 3 °C less stable than the wild type.
Unlike in the VL family, the effects of residue 2 seen in VH are
minor and not specific for any amino acid side chain tested.
Influence of Residue 2 on Domain Structure and Dynamics—
To obtain a structural understanding of the influence of the
residue at position 2 of VL, both MAK33 VL-WT and
MAK33 VL-I2E were analyzed by solution-state NMR spec-
troscopy. 71% of the non-proline residues could be assigned
(Fig. 8a). Backbone assignment was hampered by chemical
exchange dynamics. The unassigned residues mainly include
the regions from the N terminus to Pro-8, from His-41 to Tyr-
50, and from Cys-88 to Gly-101. Fig. 8b depicts chemical shift
changes caused by the I2E substitution. We find particularly
large chemical shift differences for residues Cys-23 to Ser-40
FIGURE 8. Structural properties of VL variants monitored by NMR spectroscopy. a,
1H-15N-HSQC spectra of MAK33 VL-WT and MAK33 VL-I2E. Both spectra
were acquired at a protein concentration of 50 M in 20 mM phosphate, 50 mM NaCl (pH 6.5) at 298 K on a 600 MHz spectrometer equipped with a cryoprobe.
b, chemical shift changes of MAK33 VL caused by the I2E substitution.
1H and 15N backbone chemical shifts were determined at a protein concentration of 50
M at 298 K in 20 mM phosphate, 50 mM NaCl (pH 6.5). c, effects of I2E substitution in MAK33 VL. Strongly affected residues are marked on the MAK33 VL-WT
crystal structure (PDB code 1FH5). Ile-2 is shown in red, and residues with chemical shift changes 0.05 ppm are shown in dark purple, and unassigned residues
are shown in gray.
TABLE 3
Thermal and chemical stabilities of 1AQK VL and 1VGE VH variants
Stabilities against thermal and chemical (GdmCl) denaturation of the different
1AQK VL and 1VGE VH variants are shown. Midpoints of thermal transitions are
shown as Tmelt. Because GdmCl-induced unfolding transitions acquired for 1AQK
VL were reversible, the data were fitted to a two-state equilibrium unfolding model
to obtain the thermodynamic stability of unfolding (GU), as well as the coopera-
tivity parameter (m value), for a qualitative comparison of the data. When due to too
less an amount of proteins, the chemical stability experiments could not be per-
formed (NA).





1AQK VL-WT 44.0  0.2 
5.7  1.3 13.1  1.1
AQ-N2E 44.9  0.5 
6.4  1.7 15.1  1.9
AQ-N2S 44.9  0.4 
11.1  3.0 17.8  3.6
1VGE-VH-WT 46.5  0.6 NA NA
VG-V2E 43.1  0.6 NA NA
VG-V2A 43.8  0.5 NA NA
Role of Residue 2 for Integrity of Antibody Variable Domains





















and Ser-67 to Leu-73. The first region contains the structurally
important residues Cys-23, which forms a conserved disulfide
bond with Cys-88. The adjacent Arg-24 is involved in a con-
served salt bridge with Asp-70 and the conserved Trp-35 lies in
the core of Ig domains (50). Furthermore, the I2E substitution
causes structural changes also at distant residues like Tyr-86
and Phe-87 (Fig. 8c). In consequence, a rearrangement of the
hydrophobic core involving residues Ala-25, Ile-29, Trp-35,
Leu-73, and Tyr-86, which exhibit major chemical shifts
changes, is induced. The CDRs also show shift perturbations,
especially the loop including residues Arg-24 to Ile-29, which is
close to the N terminus.
To gain further insight in the dynamics of the VL domains,
MD simulations in explicit solvent were performed on the
MAK33 VL-WT and 1OPG VL-WT domains and on the
MAK33 VL-I2E and 1OPG VL-E2I mutants. The substitu-
tions were generated in silico based on the native crystal struc-
tures followed by extensive energy minimization before starting
MD simulations (see “Experimental Procedures” for details).
For all four cases, the r.m.s.d. of the backbone stayed close to the
starting structure within 2.0 Å (Fig. 9). In the variants with an
Ile at position 2 (MAK33 VL-WT and 1OPG VL-E2I), the Ile
residue remained close to the starting conformation with the
side chain located in a hydrophobic cavity (Fig. 10, a, b, and d).
During the entire simulation, the r.m.s.d. of the heavy atoms of
Ile-2 stayed at a level similar or only slightly larger than that of
the average backbone r.m.s.d. of the complete domains (black
curves in Fig. 10, a and b). Interestingly, one can distinguish two
rotameric sub-states of the Ile side chain during the simulation
with slightly different r.m.s.d. with respect to the starting struc-
ture. Contrary to this, in the two variants with a Glu at position
2 (MAK33 VL-I2E and 1OPG VL-WT), significant deviations
and fluctuations of the Glu-2 side chains with respect to the
starting structure were observed (red curves in Fig. 10, a and b).
Deviations of up to 6 – 8 Å from the initial placement were
observed that correspond to a partial or full dissociation of the
Glu-2 side chain from the cavity, thereby adopting a fully sol-
vent-exposed conformation (compare Fig. 10, d and e). The
frequent disruption of contacts between Glu-2 and other side
chains indicates that Glu does not contribute significantly to
the stability.
The analysis of root mean square fluctuations of each residue
with respect to the mean structure (Fig. 9, c and d) showed
similar fluctuations for wild type and corresponding mutant
chains. However, significantly larger fluctuations were observed
for variants with a Glu at position 2 compared with those with
Ile-2. Slightly increased fluctuations were also seen at loop seg-
ments that flank residue 2 (e.g. the loop around Ala-25), also
identified in NMR experiments to have strong chemical shift
perturbations. To quantify the relative stability of solvent-ex-
posed and buried states of the side chain at residue 2, US sim-
ulations were performed to induce a dissociation of the side
chain from the N-terminal cavity region. The distance between
the C	 atom of residue 2 and the C	 atom of a residue at the
floor of the N-terminal contact region served as reaction coor-
dinate (see “Experimental Procedures” for details). The US sim-
ulations allowed for the calculation of a potential-of-mean
force or associated free energy change for the dissociation of
residue 2 (Fig. 10c). A distance of 12 Å corresponded to a
location of residue 2 in contact with the residues forming the
N-terminal cavity region (smaller distances resulting in sterical
repulsion). At distances of 16 –18 Å, the side chain of residue 2
FIGURE 9. a, comparison of backbone root mean square deviations (RMSD) from the corresponding experimental start structure versus data gathering
simulation time for MAK33 VL-WT (black curve) and MAK33 VL-I2E (red curve). b, same for 1OPG VL-WT (red curve) and 1OPG VL-E2I (black curve). c,
comparison of root mean square fluctuations of amino acid residues along the domain chain for 200-ns simulations of MAK33 VL-WT (black curve) and MAK33
VL-I2E (red curve). d, same for 1OPG VL-WT (red curve) and 1OPG VL-E2I (black curve).
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had lost contacts with the N-terminal cavity region (larger dis-
tances resulting in disruption of additional contacts of subse-
quent residues along the chain). The US simulations indicate a
significantly higher dissociation free energy barrier for the case
of an Ile at position 2 compared with Glu-2 in both MAK33 and
1OPG VL domains. Because in the folded form the Ile-2 resi-
due stays in an associated conformation, one can assign 2.5
kcal/mol (10 kJ mol
1) as a free energy difference of dissoci-
ation compared with Glu-2 as a folding stabilization free energy
contribution of the Ile-2 variants. This is in excellent agreement
with our experimental values.
In addition to the VL domains, the VL and VH domains
(taken from the x-ray structures of 1AQK (49) and 1VGE (39),
respectively), were also analyzed. MD simulations were per-
formed starting from the x-ray conformations of the wild type
structures and from variants with a Glu at position 2. In all
simulations, the domain conformations stayed close (within 2
Å) to the start structure for a 50-ns sampling time (Fig. 11, a and
b). In the case of 1AQK VL, the Asn-2 wild type residue is
partially solvent-exposed forming contacts with polar and
charged residues near the N terminus (Fig. 10h). During the
simulations, it transiently dissociates to more solvent-exposed
states. Similarly, the Glu-2 variant (1AQK VL-N2E) also shows
fluctuations to partially solvent-exposed states with limited
contacts to the N-terminal region of the protein (Fig. 11c). In
the case of 1VGE VH, residue 2 is in a fully solvent-exposed state
FIGURE 10. Heavy atom r.m.s.d. of residue 2 versus simulation time after best superposition on the complete backbone of the start structure for 1OPG VL-WT
(red, Glu-2) and 1OPG VL-E2I (black, Ile-2) (a) and MAK33 VL-WT (black, Ile-2) and MAK33 VL-I2E (red, Glu-2) (b). c, calculated potential-of-mean force for the
dissociation of the Glu-2 in 1OPG VL-WT (black curve), Ile-2 in 1OPG VL-E2I (green), Ile-2 in MAK33 VL-WT (red curve), and Glu-2 in MAK33 VL-I2E (blue curve)
from the hydrophobic cavity region. d, N-terminal cavity region of MAK33 VL with the Ile-2 side chain buried in the cavity (protein schematic with Ile-2 as sticks
model and adjacent side chains as van der Waals spheres). e, example of a simulation snapshot with a fully solvent-exposed Glu-2 side chain and several water
molecules at the rim of the N-terminal cavity region of 1OPG VL. f, solvent-accessible surface representation in yellow of the binding cavity region for residue
2 in the case of MAK33 VL-WT (stick model of Ile-2); g. same for 1VGE VH-WT with Val-2 as stick representation, and h, same for 1AQK VL-WT with Asn-2.
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already in the x-ray starting structure (Fig. 10g). No cavity near
the N terminus is present that could serve as a stable anchor
region for residue 2 as found for the  domains (Fig. 10f). Both
the simulations of 1VGE VH-WT and the V2E mutant showed
large fluctuations of residue 2 and no stable binding mode
could be identified (Fig. 11d). Thus, in these cases neither the
wild type nor the Glu-2 variants adopt a stable state with a
buried side chain of residue 2 that could contribute to the sta-
bility of the protein, in contrast to what was observed for the
Ile-2 variants of MAK33 and 1OPG VL. This is largely due to
the absence of an appropriate cavity region near the N terminus
and explains why mutation of residue 2 has little or no influence
on protein stability in the case of the VL and VH domains.
DISCUSSION
We show here that residue 2 is crucial for the integrity and
stability of VL domains of the  family, and this residue is a key
factor that controls its amyloidogenic properties. Specifically,
uncharged residues at position 2 of VL domains are important
for the maintenance of the structural integrity and a high sta-
bility. In agreement with their extremely low frequency in nat-
urally occurring VL domains, charged residues do not support
this.
During NMR backbone assignment, we encountered several
regions that are exchanged-broadened and therefore could not
be assigned completely. Interestingly, these regions match well
with dynamic residues in the dimer interface of the human VL
sequence LEN, as identified by Mukherjee et al. (51). In this VL
domain (LEN), residues 1–9, 37–58, and 89 –100 were shown to
exhibit pH-dependent millisecond dynamics, which seem to be
related to the process of amyloid fibril formation. The presence
of residue 2 within these dynamic regions is another indicator
for its relevance for amyloidogenicity. This is supported by our
MD simulations that show an increase in N-terminal dynamics
caused by a charged residue at position 2. Overall, the I2E sub-
stitution affects large parts of the VL structure. Both the dis-
ruption of the conserved salt bridge and the changes in the
hydrophobic core presumably contribute to the loss of thermo-
dynamic stability. However, the short strand-connecting helix
(residues 79 – 83), which is highly conserved in antibody vari-
able domains and known to be important for early folding
events of the domain (13) was not affected by the I2E substitu-
tion, implying that this replacement may not be involved in the
amyloidogenicity of the VL variants studied here.
Hydrophobic core packing is well known to be an important
stabilizing factor in proteins in general (52–54) and antibody
domains in particular (55). Therefore, the destabilizing effects
of charged residues at position 2 could be explained by the fact
that they are energetically unfavorable within the hydrophobic
core. A charged residue at position 2 of a VL domain leads to a
partial exposure of the hydrophobic interior and to the disrup-
tion of an optimal packing around residue 2. This in turn causes
rearrangements of the whole hydrophobic core region. Conse-
quently, this results in the destabilization of the fold and an
increased aggregation propensity. For the VL and VH domains,
the residue at position 2 is largely solvent-exposed or forms
only transient polar contacts with the surrounding protein sur-
face. In MD simulations, both the wild type residues at position
2 or substitutions with Glu resulted in fluctuating solvent-ex-
posed conformational states due to the lack of a stable binding
region. Hence, in the case of the VL and VH domains, residue 2
is not part of the hydrophobic core, and substitution of this
residue also does not disrupt the hydrophobic packing of the
FIGURE 11. a, comparison of backbone r.m.s.d. from the corresponding experimental start structure versus data gathering simulation time for 1AQK VL-WT
(black curve) and 1AQK VL-N2E (red curve). b, same for 1VGE VH-WT (black curve) and 1VGE VH-V2E (red curve). Heavy atom r.m.s.d. of residue 2 versus simulation
time after best superposition on the complete backbone of the start structure for 1AQK VL-WT (black, Asn-2) and 1AQK VL-N2E (red, Glu-2) (c) and 1VGE VH-WT
(black, Val-2) and 1VGE VH-V2E (red, Glu-2) (d).
Role of Residue 2 for Integrity of Antibody Variable Domains





















domains. Whereas the binding of the N-terminal segment to
the hydrophobic cavity is crucial for stability in VL domains, it
appears to be less important for VL and VH domains. Unlike in
the VL domains where the hydrophobic cavity requires bind-
ing of the N-terminal residue 2 to prevent the unfavorable
exposure of nonpolar residues, in the VL and VH domains, the
respective hydrophobic cavities are less hydrophobic and do
not require binding of residue 2 for protection.
It has been suggested that the formation of amyloid fibrils
does not begin from the native state of a protein but more likely
from a partially folded state or an intermediate state (32, 56, 57).
In this context, the occurrence of particularly nonconservative
mutations that involve a change in side chain chemistry in a
structurally important region and the correlation with an
increased propensity to form amyloid have been reported (32,
58). Mutations and changes in conditions that lead to destabi-
lization of the native state might therefore serve to increase the
population of an intermediate state or partially folded species,
thereby enabling more molecules to be diverted into an amy-
loid-forming pathway (59, 60). In this study, the less stable
MAK33 and 10PG VL variants readily formed fibrils, whereas
their stable counterparts did not. Although stability is an
important factor determining the amyloidogenic propensity of
proteins, the amino acid sequence plays a major role (61) as this
determines the amyloid fibril formation kinetics and the types
of intermediates populated (13, 32, 56). Although some resi-
dues protect against amyloid formation, their chemistry and
position within the protein appear to be more important. This
protective role is largely attributed to edge strands of -sheet
proteins (62– 64). Residue 2 in antibody variable domains
appears in -strand A, which is one of four edge strands (A, D
and C, G) of the -sandwich topology. Uncharged residues at
this position might have evolved to prevent undesirable -sheet
self-propagation (63). The frequent dissociation and solvent
exposure of charged residues at position 2 of VL domains pre-
sumably lead to the disruption of native H-bonds and the sub-
sequent exposure of H-bond donors and acceptors on the edge
strand interface. This might result in VL edge-to-edge aggrega-
tion (65). The rare occurrence of charged residues at this posi-
tion within edge strand A and the high amyloidogenic propen-
sity of these VL variants are in line with this explanation.
Although there exists a huge similarity between the three dif-
ferent families of variable domains, it has also been shown that
they differ significantly in their biophysical properties and pro-
pensity to aggregate to amyloid fibrils (55, 66). Our study iden-
tifies an important property of the VL family, not pertaining to
the VL and VH domains, which controls its amyloidogenicity.
A compelling amount of evidence from studies on sequence
and structural features that can predispose to amyloid forma-
tion has often been limited to given VL subfamilies (e.g. 1 or
6) with hardly one feature pertaining to all or an entire variable
domain family (67– 69). Our results identify a key feature that
can destabilize and as a result predispose an entire variable
domain family to fibrillar aggregation. The importance of resi-
due 2 for the VL family determined here adds to the under-
standing of antibody LC amyloidosis linking the destabilization
of native interactions with amyloid formation. In the context of
AL amyloidosis, and also in the broader context of amyloid
diseases, however, it remains to be seen whether point muta-
tions promoting fibril formation generally affect stability. It
seems reasonable to assume that other mechanisms may also
apply.
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